Onyx Scientific is set to increase the size of its UK-based site by investing in an additional site adjacent to its existing facility in North-East England Read more


As always innovation has been a key element in this year’s pharmaceutical sector. Lu Rahman handpicks her favourite stories showing the breakthroughs that have taken place over the last 12 months Read more


Cancer Research UK is using Onyx Scientific to manage several of its drug development projects in a bid to maximise value for the UK’s leading cancer charity. Read more

The chemistry specialist has decided to adopt a more novel approach to manufacturing API in a bid to overcome the often time-consuming and costly process of batch manufacturing. Read more

UK-based CMO Onyx Scientific has completed an API development and manufacturing project with US-based Neuronascent, Inc, a company that develops orally available neurogenic and neurorestorative therapeutics that target Parkinson’s disease, Down... Read more


UK-based chemistry specialist Onyx Scientific has unveiled a huge increase in demand for its solid-state chemistry services versus last year. The contract research and manufacturing organisation has reported a 45% uplift in solid formulation... Read more


Onyx Scientific has further strengthened its US team with the appointment of another business development professional. Adam Moorhouse joins the contract research and manufacturing organisation as a Director of Business Development and will be... Read more


Onyx Scientific has appointed a Chicago-based Business Development Director. Dan Brisard will oversee the contract business development activities across the eastern half of the US. Read more